JPH07206609A - Antimicrobial agent - Google Patents

Antimicrobial agent

Info

Publication number
JPH07206609A
JPH07206609A JP1406594A JP1406594A JPH07206609A JP H07206609 A JPH07206609 A JP H07206609A JP 1406594 A JP1406594 A JP 1406594A JP 1406594 A JP1406594 A JP 1406594A JP H07206609 A JPH07206609 A JP H07206609A
Authority
JP
Japan
Prior art keywords
nitrogen
salt
compound
taurine
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1406594A
Other languages
Japanese (ja)
Other versions
JP3759757B2 (en
Inventor
Keiko Kiuchi
圭子 木内
Tomoko Osumi
知子 大隅
Saburo Uchikuga
三郎 内空閑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sogo Pharmaceutical Co Ltd
Original Assignee
Sogo Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sogo Pharmaceutical Co Ltd filed Critical Sogo Pharmaceutical Co Ltd
Priority to JP01406594A priority Critical patent/JP3759757B2/en
Publication of JPH07206609A publication Critical patent/JPH07206609A/en
Application granted granted Critical
Publication of JP3759757B2 publication Critical patent/JP3759757B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PURPOSE:To provide a new type antimicrobial and antiseptic agent capable of reducing and killing various microorganisms in a wide range. CONSTITUTION:An antimicrobial agent contains a nitrogen-containing halogen compound of formula I (R1,R2 are H, methyl, carboxylmethyl, hydroxyethyl, Cl, Br or I, but at least one of the R1 and R2 is Cl, Br, I; n is 0-2; X is H, carboxyl, N,N-dicarboxymethylamino, sulfonic acid, amino, polyaminoethyl), e.g. taurine chloramine. The compound of formula I is obtained by reacting a nitrogen containing organic compound of formula II (R1,R2 are H, methyl, carboxymethyl, hydroxyethyl; n, X are the same as the n, X of formula I) or its salt with (A) a halogen or (B) a hypohalogenous acid and/or its salt, or by mixing the nitrogen-containing organic compound of formula II or its salt with (C) a halide and subsequently electrolyzing the mixture solution.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、殺菌剤に関するもので
あり、更に詳細には含窒素ハロゲン化合物を有効成分と
する新規な殺菌剤に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a fungicide, and more particularly to a novel fungicide containing a nitrogen-containing halogen compound as an active ingredient.

【0002】[0002]

【従来の技術】塩素、次亜塩素酸、次亜塩素酸塩、ジク
ロロイソシアヌル酸塩、漂白粉等の塩素系に代表される
ハロゲン系製剤は強力な酸化力を有しているが、その反
面不快なカルキ具を放つ欠点を有しているため、そのた
め殺菌剤としての使用は限定されている。特に家庭用の
殺菌剤、トイレ、居室、冷蔵庫等の殺菌剤にはカルキ臭
のため使用されない。
2. Description of the Prior Art Chlorine, hypochlorous acid, hypochlorite, dichloroisocyanurate, bleaching powder, and other halogen-based preparations represented by chlorine have strong oxidizing power, but on the other hand, they are uncomfortable. Since it has the disadvantage of releasing various bleaching tools, its use as a germicide is therefore limited. Especially, it is not used for household disinfectants, disinfectants for toilets, living rooms, refrigerators, etc. due to the smell of chlorine.

【0003】一方、タウリンクロラミンについては、生
体内で酵素、ミエロペルオキシダーゼの作用で下記化3
で示す反応式の様にしてタウリンクロラミンを生成する
ことが知られているが(Eur.J.Biochem.
Vol.45,305−312,1974)、タウリン
クロラミンが生体外において殺菌、消毒剤として使用さ
れたことは全く知られていない。
On the other hand, regarding taurine chloramine, the following chemical compound 3 is produced by the action of the enzyme myeloperoxidase in vivo.
It is known to produce taurine chloramine according to the reaction formula shown in (Eur. J. Biochem.
Vol. 45, 305-312, 1974), taurine chloramine is not known to be used as a sterilizing or disinfecting agent in vitro.

【0004】[0004]

【化3】 [Chemical 3]

【0005】[0005]

【発明が解決しようとする課題】本発明は、各種の微生
物に対して、広範に且つきわめて効率よく殺菌、消毒を
行う新規システムを開発することを目的とするものであ
る。
SUMMARY OF THE INVENTION It is an object of the present invention to develop a new system for sterilizing and disinfecting various microorganisms in a wide range and very efficiently.

【0006】[0006]

【課題を解決するための手段】本発明は、上記した目的
を達成するためになされたものであって、生体内におい
て生成するタウリンクロラミンが生体外の厳しい環境下
でも分解したりすることがなく、しかも細菌、真菌等各
種の微生物に対して広範且つきわめて強力にこれらを死
滅させるというきわめて有効な新知見を得た。そのうえ
更に、この新規にして有用な殺菌、消毒作用は他の含窒
素ハロゲン化合物にも認められることを発見し、本発明
を完成するに至った。
The present invention has been made in order to achieve the above-mentioned object, and taurine chloramine produced in vivo does not decompose even in a severe environment in vitro. Moreover, we have obtained extremely effective new knowledge that it kills various microorganisms such as bacteria and fungi extensively and extremely strongly. Furthermore, they have found that this novel and useful bactericidal and disinfecting action is also found in other nitrogen-containing halogen compounds, and completed the present invention.

【0007】すなわち本発明は、下記化4で示される一
般式(I)を有する含窒素ハロゲン化合物を含有する殺
菌剤を、その基本的技術思想とするものである。
That is, the present invention has as its basic technical idea a bactericide containing a nitrogen-containing halogen compound having the general formula (I) represented by the following chemical formula 4.

【0008】[0008]

【化4】 [Chemical 4]

【0009】本発明に係る殺菌剤は、下記化5で示され
る一般式(II)を有する含窒素有機化合物(及び/又は
その塩)をハロゲン処理して製造する。ハロゲン処理と
しては、ハロゲンとの反応、次亜ハロゲン酸/その塩と
の反応、ハロゲン化塩との混合溶液の電気分解等が挙げ
られる。
The fungicide according to the present invention is produced by subjecting a nitrogen-containing organic compound (and / or a salt thereof) having the general formula (II) shown below to halogen treatment. Examples of the halogen treatment include reaction with halogen, reaction with hypohalous acid / a salt thereof, electrolysis of a mixed solution with a halogenated salt, and the like.

【0010】[0010]

【化5】 [Chemical 5]

【0011】一般式(I)で示される化合物としては、
例えばタウリンクロラミンが例示されるが、このタウリ
ンクロラミン(タウリンモノクロラミン及び/又はタウ
リンジクロラミンをいう)を人工的に製するには: 1)タウリン/その塩と次亜塩素酸/その塩とを反応さ
せる。 2)タウリン/その塩と塩素と反応させる。 3)タウリン/その塩とハロゲン化塩の混合溶液を電気
分解する。 その他塩素以外の各種ハロゲン誘導体も上記に準じて処
理すれば容易に得ることができる。
As the compound represented by the general formula (I),
For example, taurine chloramine is exemplified. To artificially produce this taurine chloramine (referring to taurine monochloramine and / or taurine dichloramine): 1) Taurine / a salt thereof and hypochlorous acid / a salt thereof React. 2) React with taurine / salt and chlorine. 3) Electrolyze the mixed solution of taurine / a salt thereof and a halogenated salt. Various halogen derivatives other than chlorine can be easily obtained by treating according to the above.

【0012】本発明に係る殺菌剤を製造する場合、その
一方の原料化合物としては、上記したような化合物を使
用するが、その好適例としては次のようなものが例挙さ
れる:スルファミン酸、グリシン、ザルコシン、2−ア
ミノエタノール、2−アミノエタノール酸性硫酸エステ
ル、タウリン、メチルタウリン、N,N−ジヒドロキシ
エチルタウリン、エチレンジアミン、エチレンジアミン
−4酢酸(EDTA)、ポリエチレンイミン及び尿素、
アンモニア/(重)炭酸塩、こ(れら)の鉱酸塩。
In the case of producing the fungicide according to the present invention, the above-mentioned compound is used as one of the raw material compounds, and the preferable examples thereof include the following: sulfamic acid , Glycine, sarcosine, 2-aminoethanol, 2-aminoethanol acid sulfate, taurine, methyltaurine, N, N-dihydroxyethyltaurine, ethylenediamine, ethylenediamine-4acetic acid (EDTA), polyethyleneimine and urea,
Ammonia / (bi) carbonate, these mineral salts.

【0013】上記した含窒素化合物と反応するハロゲン
化合物としては、次のものが挙げられる。 1)直接反応する場合: ハロゲンガス、ハロゲン水、次亜ハロゲン酸/アルカリ
(土類)金属塩 2)電気分解の場合: ハロゲン化化合物(塩素、臭素、ヨウ素)のアルカリ
(土類)金属塩
Examples of the halogen compound which reacts with the above-mentioned nitrogen-containing compound include the following. 1) Direct reaction: Halogen gas, halogen water, hypohalous acid / alkali (earth) metal salt 2) Electrolysis: Alkali (earth) metal salt of halogenated compound (chlorine, bromine, iodine)

【0014】上記反応において、直接反応する場合、含
窒素化合物とハロゲンガス、ハロゲン水、次亜ハロゲン
酸/アルカリ(土類)金属塩を水溶液中で反応すれば良
い。また、電気分解で製する場合、含窒素化合物とハロ
ゲンの塩の水溶液を電解槽に入れ通電すれば容易に製す
ることが出来る。
In the above reaction, when the reaction is carried out directly, the nitrogen-containing compound, the halogen gas, the halogen water and the hypohalous acid / alkali (earth) metal salt may be reacted in an aqueous solution. In the case of electrolysis, it can be easily produced by putting an aqueous solution of a nitrogen-containing compound and a halogen salt in an electrolytic cell and energizing.

【0015】あるいはまた、含窒素化合物/その塩(一
般式II)と塩素系製剤とを水性系で混合することによ
り、本発明に係る水性系殺菌剤を直接製造することがで
きる。例えば、水に一般式(II)の化合物を溶解した
後、これに塩素系製剤(加水してもよい)を混合するこ
とによって、目的とする殺菌剤水溶液を直接製造するこ
とができる。この方法は、例えば用時調製の場合に特に
適している。
Alternatively, the aqueous fungicide according to the present invention can be directly produced by mixing the nitrogen-containing compound / the salt thereof (general formula II) and the chlorine-based preparation in an aqueous system. For example, by dissolving the compound of the general formula (II) in water and then mixing this with a chlorine-based formulation (which may be watered), the desired aqueous solution of the bactericide can be directly produced. This method is particularly suitable, for example, for fresh preparation.

【0016】上記において、塩素系製剤としては、塩
素、次亜塩素酸(塩)、ジクロロイソシアヌル酸塩、漂
白粉系のほか、カビキラー(商品名)その他市販品が適
宜使用できる。
In the above, as the chlorine-based preparation, chlorine, hypochlorous acid (salt), dichloroisocyanuric acid salt, bleaching powder, as well as mold killer (trade name) and other commercially available products can be appropriately used.

【0017】なお本発明において、塩とは、ナトリウ
ム、カリウム等アルカリ金属塩、カルシウム、マグネシ
ウム等アルカリ土類金属塩のほか、鉱酸塩、(重)炭酸
塩その他各種の無機又は有機の塩類を広く包含する。
In the present invention, salts include not only alkali metal salts such as sodium and potassium, alkaline earth metal salts such as calcium and magnesium, but also mineral salts, (bi) carbonates and various inorganic or organic salts. Widely include.

【0018】本発明の有効成分化合物であるタウリンク
ロラミン、N−メチルタウリンクロラミン、N−クロロ
ザルコシン等について、その生成ないしその存在は、紫
外吸収スペクトルで確認することが出来る。タウリンク
ロラミン等生成物は比較的安定であるが、使用直前に製
するのが良い。上記反応時のモル比はハロゲン原子1に
対して窒素化合物0.25モル以上、好ましくは0.5
−2モルが良い。
Regarding the active ingredient compounds of the present invention such as taurine chloramine, N-methyl taurine chloramine and N-chlorosarcosine, their production or their existence can be confirmed by the ultraviolet absorption spectrum. Products such as taurine chloramine are relatively stable, but it is better to make them just before use. The molar ratio at the time of the reaction is 0.25 mol or more, preferably 0.5, of a nitrogen compound with respect to 1 halogen atom.
-2 mol is good.

【0019】本発明に係る殺菌剤は、通常の外用殺菌、
消毒液と全く同様に使用することができる。しかも、強
い刺激等もないので、皮膚に付着しても格別の副作用も
認められず、安全性が高いという利点も奏される。
The bactericide according to the present invention is a conventional external sterilizer,
It can be used just like a disinfectant. Moreover, since there is no strong irritation, no particular side effect is observed even if it adheres to the skin, and there is an advantage that the safety is high.

【0020】更にまた、本発明においては、含窒素化合
物(一般式II)と市販の塩素系製剤とを別個に用意して
おき、使用時に両者を水性系で混合すれば自由にしかも
所望する濃度の殺菌剤を得ることができ、この点におい
ても本発明は卓越している。
Furthermore, in the present invention, a nitrogen-containing compound (general formula II) and a commercially available chlorine-based preparation are prepared separately, and when both are mixed in an aqueous system at the time of use, the desired concentration can be freely obtained. It is possible to obtain the bactericide of the present invention, and the present invention is also excellent in this respect.

【0021】以下、実施例により本発明を更に説明する
が、有効塩素イオン濃度は、その水溶液中にヨウ化カリ
ウムを添加した後、チオ硫酸ナトリウム滴定により求め
た。
The present invention will be further described below with reference to Examples. The effective chloride ion concentration was determined by titration with sodium thiosulfate after adding potassium iodide to the aqueous solution.

【0022】[0022]

【実施例1:タウリンクロラミン水溶液の調製】水50
gの入ったフラスコにタウリン11.3gを溶解し、こ
れにカビキラー(商品名:有効塩素イオン濃度3.24
%(w/w))99.05gをフラスコ内が発泡しない
ように混合した。この調製した水溶液は、有効塩素イオ
ン濃度2,000ppmであった。
[Example 1: Preparation of taurine chloramine aqueous solution] Water 50
11.3 g of taurine was dissolved in a flask containing g, and mold killer (trade name: effective chloride ion concentration 3.24) was added to the solution.
% (W / w)) 99.05 g was mixed so that the inside of the flask would not foam. The prepared aqueous solution had an effective chlorine ion concentration of 2,000 ppm.

【0023】[0023]

【実施例2:細菌に対する殺菌力試験】実施例1におい
て調製したタウリンクロラミン水溶液を所定の濃度(p
pm)に希釈し、肉汁培地に添加した。その後、同培地
で24時間培養した細菌(Escherichia c
oli K−12,Staphylococcus a
ureus 209P,Pseudomonas ae
ruginosa)をそれぞれ1白金耳接種した。37
℃で72時間培養後、培地の濁りで菌体の生死を判定し
た。対照としてタウリンクロラミンの希釈に用いた生理
食塩水で行なった。またタウリン無添加のカビキラーを
比較として用いた。結果を下記表1に示す。
[Example 2: Bactericidal test against bacteria] The aqueous taurine chloramine solution prepared in Example 1 was used at a predetermined concentration (p
pm) and added to the broth medium. Then, the bacteria (Escherichia c
oli K-12, Staphylococcus a
ureus 209P, Pseudomonas ae
ruginosa) was inoculated with 1 platinum loop each. 37
After culturing at 72 ° C. for 72 hours, the viability of the cells was determined by the turbidity of the medium. As a control, the physiological saline used for dilution of taurine chloramine was used. In addition, mold killer without taurine was used as a comparison. The results are shown in Table 1 below.

【0024】[0024]

【表1】 [Table 1]

【0025】[0025]

【実施例3:真菌に対する殺菌力試験】実施例1にて調
製したタウリンクロラミン水溶液をPD寒天培地に所定
の濃度になるように添加し、平板培地とした。これに真
菌(Penicilliumcitrinum,Asp
ergillus niger,25℃7日間培養)の
1白金耳量を5mlの懸濁液(ポリソルベート80
0.05%生理食塩水)を用いて胞子浮遊液をつくり、
その1白金耳を、薬剤添加および無添加対照平板上に画
線塗抹接種した。薬剤無添加には生理食塩水を、またタ
ウリン無添加のカビキラーを比較として用いた。25℃
7日間培養後平板上の菌体の有無で判定した。結果を下
記表2に示す。
[Example 3: Fungicidal test against fungi] The aqueous solution of taurine chloramine prepared in Example 1 was added to PD agar medium to a predetermined concentration to prepare a plate medium. Fungus (Penicillium citrinum, Asp
ergillus niger, cultivated at 25 ° C. for 7 days, 1 platinum loop volume of 5 ml of suspension (polysorbate 80)
0.05% physiological saline) to make a spore suspension,
The 1 platinum loop was streak-inoculated on a drug-added or non-added control plate. As a comparison, physiological saline was used for no drug addition, and mold killer without taurine was used for comparison. 25 ° C
After culturing for 7 days, the presence or absence of cells on the plate was judged. The results are shown in Table 2 below.

【0026】[0026]

【表2】 [Table 2]

【0027】[0027]

【実施例4:タウリンブロマミン水溶液の
調製 タウリン0.1M、臭化カリウム0.2Mを溶解した水
溶液150mlに白金電極板を用いて15Vの電圧で3
時間電気分解を行った。この水溶液は有効臭素濃度17
70ppmであった。有効臭素濃度は有効塩素濃度の測
定法に準じる。 【0028】
Example 4 Preparation of Taurine Bromamine Aqueous Solution 150 ml of an aqueous solution of taurine 0.1M and potassium bromide 0.2M was dissolved in a platinum electrode plate at a voltage of 15V to 3 ml.
Electrolysis was carried out for an hour. This aqueous solution has an effective bromine concentration of 17
It was 70 ppm. The effective bromine concentration complies with the method for measuring the effective chlorine concentration. [0028]

【実施例5:タウリンヨーダミン水溶液の
調製 タウリン0.05M、ヨウ化カリウム0.1Mを溶解し
た水溶液100mlに白金電極板を用いて15Vの電圧
で3時間電気分解を行った。この水溶液は有効ヨウ素濃
度1140ppmであった。有効ヨウ素濃度は有効塩素
濃度の測定法に準じる。 【0029】
Example 5: Preparation of taurine-iodamine aqueous solution 100 ml of an aqueous solution of taurine 0.05M and potassium iodide 0.1M was electrolyzed at a voltage of 15V for 3 hours using a platinum electrode plate. This aqueous solution had an effective iodine concentration of 1140 ppm. The effective iodine concentration conforms to the method for measuring the effective chlorine concentration. [0029]

【実施例6:真菌に対する殺菌力試験】実施例4にて調
製したタウリンブロマミン水溶液を、PD寒天培地に所
定の濃度になるように添加し、平板培地とする。これ
に、真菌(Aspergillus niger,Pe
nicillium citrinum 25℃7日間
培養)の1白金耳量を5mlの懸濁液(ポリソルベート
80 0.05%生理食塩水)を用いて胞子浮遊液をつ
くり、その1白金耳を、薬剤添加および無添加対照平板
上に画線塗抹接種する。25℃7日間培養後、平板上の
菌体の有無で判定する。結果を下記表3に示す。
Example 6: Fungicidal test against fungi The taurine bromamine aqueous solution prepared in Example 4 is added to PD agar medium to a predetermined concentration to prepare a plate medium. To this, fungus (Aspergillus niger, Pe
A spore suspension was prepared by using 5 ml of a suspension (polysorbate 80 0.05% physiological saline) of 5 ml of one platinum loop of Nichillium citrinum (cultivated at 25 ° C. for 7 days). Inoculate a streak onto a control plate. After culturing at 25 ° C. for 7 days, the presence or absence of cells on the plate is evaluated. The results are shown in Table 3 below.

【0030】[0030]

【表3】 [Table 3]

【0031】[0031]

【実施例7:真菌に対する殺菌力試験】実施例5にて調
製したタウリンヨーダミン水溶液を、PD寒天培地に所
定の濃度になるように添加し、平板培地とする。これ
に、真菌(Aspergillus niger,Pe
nicillium citrinum 25℃7日間
培養)の1白金耳量を5mlの懸濁液(ポリソルベート
80 0.05%生理食塩水)を用いて胞子浮遊液をつ
くり、その1白金耳を、薬剤添加、および無添加対照平
板上に画線塗抹接種する。25℃7日間培養後、平板上
の菌体の有無で判定する。結果を下記表4に示す。
[Example 7: Test of bactericidal activity against fungi] The taurine-iodamine aqueous solution prepared in Example 5 is added to PD agar medium to a predetermined concentration to prepare a plate medium. To this, fungus (Aspergillus niger, Pe
spore suspension was prepared by using 5 ml of a suspension (polysorbate 80 0.05% physiological saline) of 5 ml of 1 platinum loop of Nitricillium citrinum (cultivated at 25 ° C. for 7 days). Inoculate the streak onto the added control plate. After culturing at 25 ° C. for 7 days, the presence or absence of cells on the plate is evaluated. The results are shown in Table 4 below.

【0032】[0032]

【表4】 [Table 4]

【0033】[0033]

【実施例8】タウリン12.5gr(0.1モル)と有
効塩素3.55gr(0.1原子)を含有する250m
lの次亜塩素酸ソーダを混合溶解して、無色無臭のタウ
リンクロラミン溶液を得た。
Example 8 250 m containing 12.5 gr (0.1 mol) of taurine and 3.55 gr (0.1 atom) of available chlorine
1 of sodium hypochlorite was mixed and dissolved to obtain a colorless and odorless taurine chloramine solution.

【0034】[0034]

【実施例9】冷蔵庫中に内径100mm、高さ45mm
のガラス製の円筒状の電解槽に白金電極を置いて、タウ
リン5mMOL、塩化カリ10mMOLを含む100m
l溶液を18V,0.3Aで通電し3時間電気分解を行
なった。その結果、有効塩素0.14%を含むタウリン
クロラミン溶液を得た。
[Embodiment 9] Inner diameter 100 mm and height 45 mm in a refrigerator
Place a platinum electrode in a cylindrical electrolytic cell made of glass of 100mM including taurine 5mMOL and potassium chloride 10mMOL.
The 1-solution was electrified at 18 V and 0.3 A for electrolysis for 3 hours. As a result, a taurine chloramine solution containing 0.14% of available chlorine was obtained.

【0035】[0035]

【実施例10】実施例8と同様に処理して、塩素水とN
−メチルタウリンより有効塩素0.3%を含むN−メチ
ルタウリンクロラミン水溶液を得た。
[Embodiment 10] The same procedure as in Embodiment 8 is carried out to obtain chlorine water and N
An N-methyl taurine chloramine aqueous solution containing 0.3% of available chlorine was obtained from -methyl taurine.

【0036】[0036]

【実施例11】実施例9のタウリンを2−アミノエタノ
ールに、塩化カリを臭化カリに代えて、15V,0.1
5Aを流し、3時間電解を行ない、臭素を含有する殺菌
剤を得た。
[Example 11] Taurine of Example 9 was replaced with 2-aminoethanol, and potassium chloride was replaced with potassium bromide to obtain 15V, 0.1.
5A was flown and electrolysis was performed for 3 hours to obtain a bromine-containing germicide.

【0037】[0037]

【実施例12】実施例9のタウリンをエチレンジアミン
に、塩化カリを臭化カリに代えて、1.5V,0.28
Aを流し、3時間電解を行ない、臭素を含有する殺菌剤
を得た。
Example 12 1.5 V, 0.28 with taurine in Example 9 replaced with ethylenediamine and potassium chloride replaced with potassium bromide
A was flown and electrolysis was performed for 3 hours to obtain a bromine-containing germicide.

【0038】[0038]

【実施例13】ザルコシン8.9gr(0.1モル)と
有効塩素3.55gr(0.1原子)を含有する250
mlの次亜塩素酸塩を混合溶解して、無色無臭のN−ク
ロロザルコシン溶液を得た。
Example 13 250 containing 8.9 gr (0.1 mol) of sarcosine and 3.55 gr (0.1 atom) of available chlorine.
By mixing and dissolving ml of hypochlorite, a colorless and odorless N-chlorosarcosine solution was obtained.

【0039】[0039]

【発明の効果】本発明によって、各種の微生物を広範に
抑制、死滅せしめることができる新しいタイプの殺菌、
消毒剤が提供される。
INDUSTRIAL APPLICABILITY According to the present invention, a new type of sterilization capable of widely inhibiting and killing various microorganisms,
A disinfectant is provided.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 下記化1で示される一般式(I)を有す
る含窒素ハロゲン化合物を含有してなることを特徴とす
る殺菌剤。 【化1】
1. A bactericide comprising a nitrogen-containing halogen compound having the general formula (I) represented by the following chemical formula 1. [Chemical 1]
【請求項2】 一般式(I)を有する含窒素ハロゲン化
合物が、下記化2で示される一般式(II)を有する含窒
素有機化合物(その塩)を(A)〜(C)のいずれかの
方法によって処理して調製したものであること、を特徴
とする請求項1に記載の殺菌剤: (A)ハロゲンと反応させる; (B)次亜ハロゲン酸及び/又はその塩と反応させる; (C)ハロゲン化塩との混合溶液を電気分解する。 【化2】
2. A nitrogen-containing halogen compound having the general formula (I) is a nitrogen-containing organic compound having a general formula (II) represented by the following chemical formula (II) (salt thereof), which is any of (A) to (C). The bactericide according to claim 1, wherein the bactericide is treated by the method of (1): (A) is reacted with halogen; (B) is reacted with hypohalous acid and / or a salt thereof; (C) The mixed solution with the halogenated salt is electrolyzed. [Chemical 2]
【請求項3】 一般式(II)を有する含窒素化合物(そ
の塩)と塩素系製剤とを水性系で混合してなることを特
徴とする、一般式(I)を有する含窒素ハロゲン化合物
含有水性系殺菌剤。
3. A nitrogen-containing halogen compound having the general formula (I), characterized in that the nitrogen-containing compound having the general formula (II) (salt thereof) and a chlorine-based preparation are mixed in an aqueous system. Aqueous fungicide.
【請求項4】 塩素系製剤が、塩素、次亜塩素酸、次亜
塩素酸塩、ジクロロイソシアヌル酸塩、漂白粉系である
ことを特徴とする請求項3に記載の殺菌剤。
4. The bactericide according to claim 3, wherein the chlorine-based preparation is chlorine, hypochlorous acid, hypochlorite, dichloroisocyanurate, or a bleaching powder.
【請求項5】 一般式(II)を有する含窒素化合物が、
スルファミン酸、グリシン、ザルコシン、2−アミノエ
タノール、2−アミノエタノール酸性硫酸エステル、タ
ウリン、メチルタウリン、N,N−ジヒドロキシエチル
タウリン、エチレンジアミン、エチレンジアミン−4酢
酸(EDTA)、ポリエチレンイミン、尿素、アンモニ
ア、その鉱酸塩、アンモニア炭酸塩、及びアンモニア重
炭酸塩からなる群から選ばれるものであること、を特徴
とする請求項2〜請求項4のいずれか1に記載の殺菌
剤。
5. A nitrogen-containing compound having the general formula (II) is
Sulfamic acid, glycine, sarcosine, 2-aminoethanol, 2-aminoethanol acidic sulfate, taurine, methyltaurine, N, N-dihydroxyethyltaurine, ethylenediamine, ethylenediamine-4acetic acid (EDTA), polyethyleneimine, urea, ammonia, The fungicide according to any one of claims 2 to 4, which is selected from the group consisting of the mineral acid salt, ammonia carbonate, and ammonia bicarbonate.
【請求項6】 タウリンクロラミンの水溶液を有効成分
とすることを特徴とする殺菌剤。
6. A fungicide, which comprises an aqueous solution of taurine chloramine as an active ingredient.
JP01406594A 1994-01-13 1994-01-13 Fungicide Expired - Fee Related JP3759757B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP01406594A JP3759757B2 (en) 1994-01-13 1994-01-13 Fungicide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP01406594A JP3759757B2 (en) 1994-01-13 1994-01-13 Fungicide

Publications (2)

Publication Number Publication Date
JPH07206609A true JPH07206609A (en) 1995-08-08
JP3759757B2 JP3759757B2 (en) 2006-03-29

Family

ID=11850700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP01406594A Expired - Fee Related JP3759757B2 (en) 1994-01-13 1994-01-13 Fungicide

Country Status (1)

Country Link
JP (1) JP3759757B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022118A1 (en) * 2000-09-14 2002-03-21 Waldemar Gottardi Fungicidal agent containing n-chlorotaurine and use thereof
FR2819723A1 (en) * 2001-01-23 2002-07-26 Arnaud Mainnemare HALOGEN COMPOSITION, PREPARATION METHOD AND USES THEREOF
WO2006081392A1 (en) * 2005-01-25 2006-08-03 Novabay Pharmaceuticals, Inc. N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids
US7285221B2 (en) 2002-05-22 2007-10-23 Kurita Water Industries, Ltd. Composition for preventing of slime and method for preventing slime
JP2011500761A (en) * 2007-10-23 2011-01-06 ノボザイムス アクティーゼルスカブ Method for killing spores and for disinfecting or sterilizing equipment
JP2011502955A (en) * 2006-12-29 2011-01-27 ノバベイ・ファーマシューティカルズ・インコーポレイテッド N-halogenated amino compounds and derivatives
US7893109B2 (en) 2003-08-18 2011-02-22 Novabay Pharmaceuticals, Inc. N,N-dihalogenated amino acids and derivatives
JP4789130B2 (en) * 2000-10-26 2011-10-12 株式会社 資生堂 Hair restoration

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022118A1 (en) * 2000-09-14 2002-03-21 Waldemar Gottardi Fungicidal agent containing n-chlorotaurine and use thereof
JP4789130B2 (en) * 2000-10-26 2011-10-12 株式会社 資生堂 Hair restoration
US7879366B2 (en) 2001-01-23 2011-02-01 Arnaud Mainnemare Halogenated composition, method for preparing same and uses thereof
FR2819723A1 (en) * 2001-01-23 2002-07-26 Arnaud Mainnemare HALOGEN COMPOSITION, PREPARATION METHOD AND USES THEREOF
WO2002058692A3 (en) * 2001-01-23 2003-12-24 Arnaud Mainnemare Halogenated composition, method for preparing same and uses thereof
US8709498B2 (en) 2001-01-23 2014-04-29 Arnaud Mainnemare Method of stimulating tissue healing
JP2013189477A (en) * 2001-01-23 2013-09-26 Arnaud Mainnemare Pharmaceutical composition including halogenated compound, method for preparing the same, and use thereof
JP2010174050A (en) * 2001-01-23 2010-08-12 Arnaud Mainnemare Medicine composition containing halogenated compound, method for preparing the same, and use thereof
US7285221B2 (en) 2002-05-22 2007-10-23 Kurita Water Industries, Ltd. Composition for preventing of slime and method for preventing slime
US7893109B2 (en) 2003-08-18 2011-02-22 Novabay Pharmaceuticals, Inc. N,N-dihalogenated amino acids and derivatives
AU2006208046B2 (en) * 2005-01-25 2011-03-24 Novabay Pharmaceuticals, Inc. N-halogenated amino acids and N, N-dihalogenated amino acids in combination with hypohalous acids
US7846971B2 (en) 2005-01-25 2010-12-07 Novabay Pharmaceuticals, Inc. N-halogenated amino acids, N,N-dihalogenated amino acids and derivatives; compositions and methods of using them
TWI386201B (en) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-halogenated amino acids, n, n-dihalogenated amino acids and deriavtives; compositions and methods of using them
JP2008531479A (en) * 2005-01-25 2008-08-14 ノバベイ・ファーマシューティカルズ・インコーポレイテッド N-halogenated amino acids and N, N-dihalogenated amino acids in combination with hypohalous acid
WO2006081392A1 (en) * 2005-01-25 2006-08-03 Novabay Pharmaceuticals, Inc. N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids
JP2011502955A (en) * 2006-12-29 2011-01-27 ノバベイ・ファーマシューティカルズ・インコーポレイテッド N-halogenated amino compounds and derivatives
JP2011500761A (en) * 2007-10-23 2011-01-06 ノボザイムス アクティーゼルスカブ Method for killing spores and for disinfecting or sterilizing equipment

Also Published As

Publication number Publication date
JP3759757B2 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
US8945630B2 (en) Method of producing and applications of composition of hypochlorous acid
CN103501605B (en) A stable composition of HOCl, processes for its production and uses thereof
ES2243569T3 (en) COMPOSITION OF HYPOCLOROUS ACID AND ITS APPLICATIONS.
KR101925900B1 (en) Hypochlorous acid water with improved long-term preservability and method for producing the same
JP2003503323A (en) N-chlorosulfamate composition with enhanced antibacterial effect
US20140328945A1 (en) METHOD FOR STABILIZING AN ELECTROCHEMICALLY GENERATED SANITIZING SOLUTION HAVING A PREDETERMINED LEVEL OF FREE AVAILABLE CHLORINE AND pH
JP2003146817A (en) Antimicrobial algicidal agent composition, method for killing microbe and alga in water system and method for producing antimicrobial algicidal agent composition
CN105836860B (en) A kind of stable type dioxygen aqueous disinfectant and its application in drinking water disinfection
JP3759757B2 (en) Fungicide
CN101006782A (en) Preparation method of a stable high potential chlorine-containing disinfection liquid
ATE320187T1 (en) BIOCIDAL APPLICATIONS OF CONCENTRATED AQUEOUS BROMOCHLORIDE SOLUTIONS
US20220355283A1 (en) Drug, drug manufacturing method, and water purification method
JP2004002229A (en) Method for sterilization
JP4494010B2 (en) Method for producing substantially chlorite-free and stable aqueous chlorine oxygen solution, chlorine oxygen solution obtained by this method, and use thereof
DE102005023198B4 (en) Aqueous chloramine-containing solutions
JP2001253803A (en) Bactericidal composition
RU2757361C1 (en) Desinfection agent
CN113383789B (en) Hypochlorous acid aqueous solution and preparation method and application thereof
KR101140147B1 (en) Compositoin for disinfection and deodorization and disinfectant for feed of livestock including the same
CA2085167C (en) Disinfectant for use in aqueous systems
RU2192392C1 (en) Composite for water treatment
JP2002502372A (en) Disinfectant preparation
JP2001226208A (en) Microbiocidal composition
RU2243765C1 (en) Disinfecting agent
WO2022266698A1 (en) Stabilised hypohalous acid solutions

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040817

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041013

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041014

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060104

A61 First payment of annual fees (during grant procedure)

Effective date: 20060105

Free format text: JAPANESE INTERMEDIATE CODE: A61

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees